78733-46-7

Basic information

• Product Name: Glycine, N-phenyl-, methyl ester, hydrochloride
• CAS NO: 78733-46-7
• Molecular Formula: C9H11NO2.ClH
• Molecular Weight: 201.653
• Mol File: 78733-46-7.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Glycine, N-phenyl-, methyl ester, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-phenyl-, methyl ester, hydrochloride(78733-46-7)
• EPA Substance Registry System: Glycine, N-phenyl-, methyl ester, hydrochloride(78733-46-7)

Safety Data

• Hazardous Substances Data: 78733-46-7(Hazardous Substances Data)

Upstream product

• 103-01-5 N-Phenylglycine 
• 75-36-5 acetyl chloride 
• 67-56-1 methanol 

Downstream Products

• 111098-94-3 (2S,4R,5S)-1,5-Diphenyl-pyrrolidine-2,4-dicarboxylic acid dimethyl ester 
• 144426-43-7 (Phenyl-{2-[4-((E)-styryl)-phenoxy]-acetyl}-amino)-acetic acid methyl ester 
• 130360-78-0 Methyl (+/-)-α-(1-phenylmethyl-3-indolylmethyl)aminophenylacetate 
• 439087-56-6 1,1-Dioxo-3-butyl-3-ethyl-5-phenyl-7-carboxymethylthio-8-[N-α-carboxybenzyl carbamoylmethoxy]-2,3,4,5-tetrahydro-1,5-benzothiazepine 
• 142114-83-8 N-(2-Azidobenzoyl)-N-phenylglycine methyl ester 
• 144426-45-9 [(2-{4-[(E)-2-(4-Chloro-phenyl)-vinyl]-phenoxy}-acetyl)-phenyl-amino]-acetic acid methyl ester 
• 111098-96-5 (2S,3S,4R,5R)-4-Nitro-1,3,5-triphenyl-pyrrolidine-2-carboxylic acid methyl ester 

Relevant articles and documents

Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.